MDGL Madrigal Pharmaceuticals, Inc.
Healthcare$524.10+0.00%OpenMarket Cap: $12.08B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$731.25
Target (Median)
$679.00
Target Range
$571.00 - $964.00
Upside from current price: 39.5%
Rating Distribution
3 Strong Buy11 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Truist Securities | maintain | Buy | Buy |
| 2026-05-07 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-07 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-06 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-20 | B of A Securities | maintain | Neutral | Neutral |
| 2026-01-20 | Citizens | maintain | Market Outperform | Market Outperform |
| 2025-12-19 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-11 | B. Riley Securities | maintain | Buy | Buy |
| 2025-11-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-20 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $10.54 | $2.22B | 8 |
| Sun Dec 31 | $26.69 | $3.00B | 11 |
| Mon Dec 31 | $43.23 | $3.95B | 4 |
| Tue Dec 31 | $62.31 | $4.97B | 4 |